Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Optinose
AddedFeb 20, 2024
UpdatedJun 18, 2026
Optinose

Optinose

Public

Optinose, Inc.: A specialty pharmaceutical firm innovating ENT and allergy treatments.

HQ
Yardley, PA, US
Founded
2010
Overview
Compare
Employees
Website

Optinose, Inc., founded in Yardley, United States, is a specialty pharmaceutical company dedicated to developing and commercializing innovative treatments for patients with diseases managed by ear, nose, and throat (ENT) and allergy specialists. The company's core mission is to enhance the quality of life for patients through advanced therapeutic solutions. Optinose's product portfolio focuses on addressing unmet medical needs in the ENT and allergy sectors, aiming to become a leading entity in this specialized market.

Notable figures associated with Optinose include key industry experts and investors who have supported its growth and innovation. The company has achieved significant milestones, such as the successful development and market introduction of novel therapeutic products that have positively impacted patient care. Optinose's contributions have been recognized within the pharmaceutical industry, underscoring its role in advancing treatment options for ENT and allergy-related conditions.

Optinose - Similar Companies

OptioRx logo

OptioRx

optiorx.com

Otologic Pharmaceutics logo

Otologic Pharmaceutics

Hyperion DeFi logo

Hyperion DeFi

eyenovia.com

Aptinyx logo

Aptinyx

aptinyx.com

Ocuphire Pharma logo

Ocuphire Pharma

ocuphire.com

Accuitis logo

Accuitis

accuitis.com

Excelent logo

Excelent

Eton Pharmaceuticals logo

Eton Pharmaceuticals

ENT Biotech Solutions logo

ENT Biotech Solutions

Lyra Therapeutics logo

Lyra Therapeutics

Sound Pharmaceuticals logo

Sound Pharmaceuticals

Visiox logo

Visiox

visioxpharma.com

Okogen logo

Okogen

okogen.com

Optivia logo

Optivia

ARS Pharmaceuticals logo

ARS Pharmaceuticals

ars-pharma.com

Optinose - Quick Facts

Who are Optinose's competitors?

Companies similar to Optinose include OptioRx, Otologic Pharmaceutics, Hyperion DeFi and Aptinyx.

When was Optinose founded?

Optinose was founded in 2010.

Where is Optinose's headquarters located?

Optinose's headquarters is located in Yardley, PA, US.

How many employees does Optinose have?

Optinose has 141 employees as of Feb 6, 2024.

Optinose - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Consumers
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 21 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 423000Merchant Wholesalers, Durable Goods
  • 423400Professional and Commercial Equipment and Supplies Merchant Wholesalers
  • 423450Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers
  • 420000Wholesale Trade
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 5000Wholesale Trade-durable Goods
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 5040Professional And Commercial Equipment And Supplies
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 5047Medical, Dental, And Hospital Equipment And Supplies
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research